JGBLI will cooperate with Korea and the U.S. government, enterprises, universities, laboratories, etc in order to provide the best quality of consultation

  • FDA approval procedures, education for new drug development, licensing for medical devices, cosmetics, and health functional food
  • Agency services for registration of the U.S. FDA GMP factories and products
  • Share the research results of NIH and acquire research fund supporting
  • Technology Transfer: new drug development and medical devices of Johns Hopkins University
  • Technology Transfer: new drug development and medical devices of University of Maryland, Medical and Pharmacy
  • CRO business agency : Amarex
  • Agency for co-research and development of traditional Korean medicine and clinical trials
  • Business agency for Bio Park Cluster, University of Maryland
  • Connection with Maryland Bio Center, drug development, and bio- similar. Establishment of factory in the U.S.
  • Research grant from BioHealth Innovation(BHI) and the federal government
  • Newest information of drugs and establish investment seminars with BIO Century, well-known bio-specialized media group.
  • Joint company, M&A, patent, licensing for the advancement in the U.S. market